| # | Drug | Count |
|---|---|---|
| 0 | COPPER | 2531 |
| 1 | ADALIMUMAB | 2271 |
| 2 | INSULIN GLARGINE | 1718 |
| 3 | EVOLOCUMAB | 1524 |
| 4 | TIRZEPATIDE | 1282 |
| 5 | ETANERCEPT | 1153 |
| 6 | INSULIN LISPRO | 914 |
| 7 | INTERFERON BETA-1A | 824 |
| 8 | ERENUMAB-AOOE | 579 |
| 9 | DUPILUMAB | 562 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COPPER | 2531 | 0.0586 |
| 1 | GOLIMUMAB | 270 | 0.0214 |
| 2 | TESTOSTERONE ENANTHATE | 34 | 0.0207 |
| 3 | ALIROCUMAB | 357 | 0.0139 |
| 4 | ERENUMAB-AOOE | 579 | 0.0104 |
| 5 | ENOXAPARIN SODIUM | 546 | 0.0094 |
| 6 | INSULIN GLARGINE AND LIXISENATIDE | 34 | 0.0093 |
| 7 | EVOLOCUMAB | 1524 | 0.0092 |
| 8 | PEGFILGRASTIM | 92 | 0.0077 |
| 9 | GALCANEZUMAB-GNLM | 236 | 0.0073 |
| # | Drug class | Count |
|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 2535 |
| 1 | Insulin Analog [EPC] | 2495 |
| 2 | GLP-1 Receptor Agonist [EPC] | 2072 |
| 3 | PCSK9 Inhibitor [EPC] | 1874 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 1508 |
| 5 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 1282 |
| 6 | Interferon beta [EPC] | 884 |
| 7 | Interleukin-4 Receptor alpha Antagonist [EPC] | 562 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 340 |
| 9 | Corticosteroid [EPC] | 338 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 1874 | 0.0728 |
| 1 | Copper-containing Intrauterine Device [EPC] | 2535 | 0.0512 |
| 2 | Interleukin-5 Antagonist [EPC] | 20 | 0.0291 |
| 3 | Provitamin D2 Compound [EPC] | 211 | 0.0071 |
| 4 | Serotonin-4 Receptor Agonist [EPC] | 4 | 0.0061 |
| 5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 10 | 0.0056 |
| 6 | Insulin Analog [EPC] | 2495 | 0.0056 |
| 7 | Vitamin K [EPC] | 48 | 0.0055 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 11 | 0.0053 |
| 9 | Interleukin-17A Antagonist [EPC] | 182 | 0.0049 |